Aardvark Therapeutics (AARD) Stock: Why It's Up Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $3.83 as of 12:05 PM ET, +1.19% vs the prior close of $3.78.
- Volume 70.08K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AARD rises 1.2% to $3.83. Trading at $3.83 (intraday, 12:05 PM ET), +1.19% vs the prior close of $3.78. Day range $3.64–$4.05, opened at $3.87.
AARD daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — AARD rises 1.2% to $3.83
- Trading at $3.83 (intraday, 12:05 PM ET), +1.19% vs the prior close of $3.78. Day range $3.64–$4.05, opened at $3.87.
- Volume was 70.08K shares, 0.5x its 50-day average of 130.90K — lighter than usual.
- Price is -31.3% vs its 50-day average ($5.56) and -44.2% vs its 200-day average ($6.86).
- 52-week range $3.35–$16.60; the current price sits at 4% of that range, 77.0% below the 52-week high.
Oct 16, 2026 — AARD dips 2.1% to $3.78, a 3-month low, 5 down days in a row
- Closed at $3.78, -2.07% vs the prior close of $3.86. Day range $3.73–$4.19, opened at $4.19.
- Volume was 97.16K shares, 0.7x its 50-day average of 130.21K.
- Price is -33.1% vs its 50-day average ($5.65) and -45.2% vs its 200-day average ($6.90).
- 52-week range $3.35–$16.60; today's close sits at 3% of that range, 77.2% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — AARD dips 0.5% to $3.86, a 3-month low, 4 down days in a row
- Closed at $3.86, -0.52% vs the prior close of $3.88. Day range $3.77–$3.98, opened at $3.86.
- Volume was 68.80K shares, 0.5x its 50-day average of 132.76K — lighter than usual.
- Price is -32.5% vs its 50-day average ($5.72) and -44.5% vs its 200-day average ($6.95).
- 52-week range $3.35–$16.60; today's close sits at 4% of that range, 76.7% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — AARD slides 4.0% to $3.88, a 3-month low, 3 down days in a row
- Closed at $3.88, -3.96% vs the prior close of $4.04. Day range $3.83–$4.35, opened at $3.93.
- Volume was 126.10K shares, 0.9x its 50-day average of 132.87K.
- Price is -33.0% vs its 50-day average ($5.79) and -44.6% vs its 200-day average ($7.00).
- 52-week range $3.35–$16.60; today's close sits at 4% of that range, 76.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — AARD slides 9.2% to $4.04, a 3-month low
- Closed at $4.04, -9.21% vs the prior close of $4.45. Day range $4.03–$4.63, opened at $4.44.
- Volume was 218.30K shares, 1.7x its 50-day average of 130.43K.
- Price is -31.0% vs its 50-day average ($5.86) and -42.7% vs its 200-day average ($7.05).
- 52-week range $3.35–$16.60; today's close sits at 5% of that range, 75.7% below the 52-week high.
Oct 12, 2026 — AARD slides 6.5% to $4.45, a 3-month low
- Closed at $4.45, -6.51% vs the prior close of $4.76. Day range $4.40–$4.88, opened at $4.81.
- Volume was 99.90K shares, 0.8x its 50-day average of 130.22K.
- Price is -24.8% vs its 50-day average ($5.92) and -37.3% vs its 200-day average ($7.10).
- 52-week range $3.35–$17.06; today's close sits at 8% of that range, 73.9% below the 52-week high.
Oct 9, 2026 — AARD rises 1.1% to $4.76
- Closed at $4.76, +1.06% vs the prior close of $4.71. Day range $4.60–$4.82, opened at $4.61.
- Volume was 140.90K shares, 1.1x its 50-day average of 130.45K.
- Price is -20.1% vs its 50-day average ($5.96) and -33.4% vs its 200-day average ($7.15).
- 52-week range $3.35–$17.23; today's close sits at 10% of that range, 72.4% below the 52-week high.
Oct 8, 2026 — AARD slides 5.0% to $4.71, a 3-month low on 2.5x normal volume
- Closed at $4.71, -5.04% vs the prior close of $4.96. Day range $4.57–$5.09, opened at $4.77.
- Volume was 316.00K shares, 2.5x its 50-day average of 127.61K — unusually heavy trading.
- Price is -21.4% vs its 50-day average ($5.99) and -34.5% vs its 200-day average ($7.20).
- 52-week range $3.35–$17.94; today's close sits at 9% of that range, 73.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 7, 2026 — AARD dips 1.6% to $4.96
- Closed at $4.96, -1.59% vs the prior close of $5.04. Day range $4.69–$5.33, opened at $4.95.
- Volume was 212.00K shares, 1.7x its 50-day average of 124.44K.
- Price is -17.4% vs its 50-day average ($6.01) and -31.5% vs its 200-day average ($7.24).
- 52-week range $3.35–$17.94; today's close sits at 11% of that range, 72.4% below the 52-week high.
Oct 6, 2026 — AARD slides 3.4% to $5.04 on 2.1x normal volume
- Closed at $5.04, -3.45% vs the prior close of $5.22. Day range $4.66–$5.45, opened at $5.28.
- Volume was 251.90K shares, 2.1x its 50-day average of 120.81K — unusually heavy trading.
- Price is -16.5% vs its 50-day average ($6.03) and -30.8% vs its 200-day average ($7.28).
- 52-week range $3.35–$17.94; today's close sits at 12% of that range, 71.9% below the 52-week high.
Oct 5, 2026 — AARD jumps 4.6% to $5.22
- Closed at $5.22, +4.61% vs the prior close of $4.99. Day range $5.03–$5.37, opened at $5.03.
- Volume was 61.30K shares, 0.5x its 50-day average of 122.02K — lighter than usual.
- Price is -14.0% vs its 50-day average ($6.07) and -28.7% vs its 200-day average ($7.33).
- 52-week range $3.35–$17.94; today's close sits at 13% of that range, 70.9% below the 52-week high.
Oct 2, 2026 — AARD slides 5.3% to $4.99, 3 down days in a row
- Closed at $4.99, -5.31% vs the prior close of $5.27. Day range $4.88–$5.66, opened at $5.37.
- Volume was 147.70K shares, 1.2x its 50-day average of 122.78K.
- Price is -18.1% vs its 50-day average ($6.09) and -32.3% vs its 200-day average ($7.37).
- 52-week range $3.35–$17.94; today's close sits at 11% of that range, 72.2% below the 52-week high.
- That makes 3 straight losses.
AARD bull case vs bear case (from the data)
- Insiders made 8 open-market purchases in the last 12 months.
- Price is -31.3% vs its 50-day average — short-term trend is down.
- Price is -44.2% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $57.59M.
- High volatility: average daily move of 3.4% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
AARD latest news & SEC filings
Every SEC filing by or about AARD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 8, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sun Nelson sold 62,000 shares at $5.18 (≈$321.16K) on Sep 11, 2026
- Sun Nelson sold 62,000 shares at $5.18 (≈$321.16K) on Sep 11, 2026
- Sun Nelson sold 62,000 shares at $5.18 (≈$321.16K) on Sep 11, 2026
- Sun Nelson sold 62,000 shares at $5.18 (≈$321.16K) on Sep 11, 2026
- Sun Nelson sold 14,754 shares at $5.00 (≈$73.77K) on Sep 10, 2026
- Sun Nelson sold 14,754 shares at $5.00 (≈$73.77K) on Sep 10, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$14.39M (prior year -$14.37M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.66 (prior year -$0.66) ( vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 10, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Jul 10, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jun 29, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Things to know before you trade AARD
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 23, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.36% (largest 9.2%). That is a volatile stock.
- Liquidity: about 115.50K shares (≈$441.78K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.83 vs a range of $3.35–$16.60 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 8 sales; latest: Nelson Sun sold 62,000 shares on Sep 11, 2026.
- Latest filings: 8-K Oct 8, 2026; 8-K Aug 17, 2026; 10-Q Aug 11, 2026.
- Share count: 21.88M shares outstanding (Jul 31, 2026), +0.9% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AARD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 3.87 | 4.05 | 3.64 | 3.83 | 70.08K |
| Oct 16, 2026 | 4.19 | 4.19 | 3.73 | 3.78 | 97.20K |
| Oct 15, 2026 | 3.86 | 3.98 | 3.77 | 3.86 | 68.80K |
| Oct 14, 2026 | 3.93 | 4.35 | 3.83 | 3.88 | 126.10K |
| Oct 13, 2026 | 4.44 | 4.63 | 4.03 | 4.04 | 218.30K |
| Oct 12, 2026 | 4.81 | 4.88 | 4.40 | 4.45 | 99.90K |
| Oct 9, 2026 | 4.61 | 4.82 | 4.60 | 4.76 | 140.90K |
| Oct 8, 2026 | 4.77 | 5.09 | 4.57 | 4.71 | 316.00K |
| Oct 7, 2026 | 4.95 | 5.33 | 4.69 | 4.96 | 212.00K |
| Oct 6, 2026 | 5.28 | 5.45 | 4.66 | 5.04 | 251.90K |
| Oct 5, 2026 | 5.03 | 5.37 | 5.03 | 5.22 | 61.30K |
| Oct 2, 2026 | 5.37 | 5.66 | 4.88 | 4.99 | 147.70K |
| Oct 1, 2026 | 5.29 | 5.42 | 5.13 | 5.27 | 47.80K |
| Sep 30, 2026 | 5.42 | 5.52 | 5.27 | 5.27 | 28.10K |
| Sep 29, 2026 | 5.21 | 5.39 | 5.00 | 5.35 | 39.60K |
| Sep 28, 2026 | 5.05 | 5.32 | 4.96 | 5.27 | 60.60K |
| Sep 25, 2026 | 5.57 | 5.60 | 5.02 | 5.06 | 71.50K |
| Sep 24, 2026 | 5.55 | 5.69 | 5.32 | 5.55 | 96.10K |
| Sep 23, 2026 | 5.74 | 5.74 | 5.41 | 5.56 | 54.80K |
| Sep 22, 2026 | 5.51 | 5.84 | 5.50 | 5.75 | 101.30K |
About Aardvark Therapeutics
Aardvark Therapeutics (AARD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1774857.
AARD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Roy D. Baynes | Director | Aug 21, 2026 |
| Jeffrey Chi | Director | Aug 21, 2026 |
| Susan E Graf | Director | Aug 21, 2026 |
| Tien-Li Lee | Chief Executive Officer | Feb 11, 2026 |
| Victor Edward Jr Tong | Director | Aug 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Manasi Jaiman | Chief Medical Officer | Feb 11, 2026 |
| Bryan Jones | Chief Operating Officer | Oct 16, 2025 |
| Tien-Li Lee | Chief Executive Officer | Feb 11, 2026 |
| Nelson Sun | See Remarks | Sep 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Nelson Sun | Sale | 62,000 | $5.18 |
| Sep 11, 2026 | Nelson Sun | Sale | 62,000 | $5.18 |
| Sep 11, 2026 | Nelson Sun | Sale | 62,000 | $5.18 |
| Sep 11, 2026 | Nelson Sun | Sale | 62,000 | $5.18 |
| Sep 10, 2026 | Nelson Sun | Sale | 14,754 | $5.00 |
| Sep 10, 2026 | Nelson Sun | Sale | 14,754 | $5.00 |
| Sep 10, 2026 | Nelson Sun | Sale | 14,754 | $5.00 |
| Sep 10, 2026 | Nelson Sun | Sale | 14,754 | $5.00 |
| Dec 11, 2025 | Tien-Li Lee | Buy | 7,000 | $14.49 |
| Dec 11, 2025 | Tien-Li Lee | Buy | 7,000 | $14.49 |
| Dec 11, 2025 | Tien-Li Lee | Buy | 7,000 | $14.49 |
| Dec 11, 2025 | Tien-Li Lee | Buy | 7,000 | $14.49 |
| Dec 11, 2025 | Nelson Sun | Buy | 3,000 | $14.40 |
| Dec 11, 2025 | Nelson Sun | Buy | 3,000 | $14.40 |
| Dec 11, 2025 | Nelson Sun | Buy | 3,000 | $14.40 |
AARD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-57.59M | -2.93 | $-54.17M |
| Dec 31, 2024 | — | $-20.59M | -5.15 | $-18.09M |
Latest balance sheet: total assets $81.46M, total liabilities $6.66M, cash $73.85M (as of Jun 30, 2026).
AARD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $7.19 |
| May 7, 2026 | 8-K Item 2.02 (results) | $5.60 |
| Mar 23, 2026 | 8-K Item 2.02 (results) | $4.07 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $10.86 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $11.20 |
| May 14, 2025 | 8-K Item 2.02 (results) | $8.74 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $7.51 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on AARD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.